Search Results 491-500 of 16867 for Antagonist

  1. Publications - Erik J. Tryggestad, Ph.D. - Mayo Clinic

    Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Mol Cancer Ther ...

  2. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

    Lymphocyte homing antagonists in the treatment of inflammatory bowel diseases. ... Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel ...

  3. Atrial Fibrillation Clinical Trials - Mayo Clinic Research

    Some patients also get new heart valves using a catheter. Often doctors give patients a medicine called a vitamin K antagonist (VKA), because it is considered ...

  4. Publications - Patricio Escalante, M.D., M.S. - Mayo Clinic

    Diagnosis and Management of Latent Tuberculosis and Tuberculosis in Candidates for TNF-alpha Antagonist Therapy: An Expert Survey J of Mycobac Dis.2014, Oct ...

  5. Cervical Spinal Cord Stimulation in Cerebral Vasospasm - Mayo Clinic

    Fluid management and calcium antagonist have a beneficial effect on cerebral vasospasm following SAH, but is not tolerated or is ineffective in some patients.

  6. A Study to Assess Anal Pressures by Manometry in Health People - Mayo Clinic

    Medications that may alter gastrointestinal motility, e.g., serotoninergic agents, alpha adrenergic agonists or antagonists, calcium channel blockers or opiates ...

  7. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  8. Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer - Mayo Clinic

    No more than 7 days of prior use of mixed opioid agonist/opioid antagonists or other opioid antagonists within 4 weeks before registration. Patients should ...

  9. A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification - Mayo Clinic

    Nitrate use or α-antagonist medication use within 24 hours; Systolic blood pressure <110 mm Hg; Mean systemic arterial pressure <75 mm Hg; Severe mitral or ...

  10. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    Patients requiring therapeutic anticoagulation with warfarin or another Vitamin K antagonist * Current treatment with strong cytochrome P450 (CYP) 3A4 ...